Toll-like receptor 2 signalling as a potential therapeutic target in gastric cancer

West, Alison (Primary Chief Investigator (PCI))

Hudson Institute - Department of Molecular and Translational Science

Project: Research

Status	Relinquished
Effective start/end date	1/01/15 → 29/06/20

Funding

National Health and Medical Research Council (NHMRC) (Australia): A$309,436.00